111 related articles for article (PubMed ID: 25091478)
21. Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger.
Lule S; Colpak AI; Balci-Peynircioglu B; Gursoy-Ozdemir Y; Peker S; Kalyoncu U; Can A; Tekin N; Demiralp D; Dalkara T
J Autoimmun; 2017 Nov; 84():87-96. PubMed ID: 28844827
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of the carboxy-terminal region of Sip-1, a novel autoantigen in Behçet's disease.
Delunardo F; Conti F; Margutti P; Alessandri C; Priori R; Siracusano A; Riganò R; Profumo E; Valesini G; Sorice M; Ortona E
Arthritis Res Ther; 2006; 8(3):R71. PubMed ID: 16611372
[TBL] [Abstract][Full Text] [Related]
23. Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.
Mor F; Weinberger A; Cohen IR
Eur J Immunol; 2002 Feb; 32(2):356-65. PubMed ID: 11807775
[TBL] [Abstract][Full Text] [Related]
24. Streptococcus sanguinis and the sera of patients with Behçet's disease stimulate membrane expression of α-enolase in human dermal microvascular endothelial cells.
Cho S; Zheng Z; Cho SB; Choi MJ; Lee KH; Bang D
Arch Dermatol Res; 2013 Apr; 305(3):223-32. PubMed ID: 23131860
[TBL] [Abstract][Full Text] [Related]
25. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
Wang X; Zhang MF; Xie J; Li ZL; Wang P
Anat Rec (Hoboken); 2012 Jul; 295(7):1168-73. PubMed ID: 22641412
[TBL] [Abstract][Full Text] [Related]
26. Expression correlates between Annexin A1 and A2 autoantibodies in patients with Behçet's disease.
Hussain M; Chen P; Mei G; Li Y; Du H
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 28963375
[TBL] [Abstract][Full Text] [Related]
27. Behçet's disease sera containing antiendothelial cell antibodies promote adhesion of T lymphocytes to cultured human dermal microvascular endothelial cells.
Lee KH; Chung HS; Bang D; Lee S
Yonsei Med J; 1999 Apr; 40(2):152-8. PubMed ID: 10333719
[TBL] [Abstract][Full Text] [Related]
28. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
29. Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases.
Bouillet L; Baudet AE; Deroux A; Sidibé A; Dumestre-Perard C; Mannic T; Treillard B; Arboleas MA; Chiquet CA; Gulino-Debrac DG; Vilgrain IY
Lab Invest; 2013 Nov; 93(11):1194-202. PubMed ID: 24061286
[TBL] [Abstract][Full Text] [Related]
30. Proteomic surveillance of autoantigens in patients with Behcet's disease by a proteomic approach.
Ooka S; Nakano H; Matsuda T; Okamoto K; Suematsu N; Kurokawa MS; Ohtani-Kaneko R; Masuko K; Ozaki S; Kato T
Microbiol Immunol; 2010 Jun; 54(6):354-61. PubMed ID: 20536734
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
32. Anti-endothelial cell antibodies in Behçet's disease.
Dinc A; Takafuta T; Jiang D; Melikoglu M; Saruhan-Direskeneli G; Shapiro SS
Clin Exp Rheumatol; 2003; 21(4 Suppl 30):S27-30. PubMed ID: 14727455
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies against complement C1q in patients with Behcet's disease: association with vascular involvement.
Bassyouni IH; Gamal S; Talaat RM; Siam I
Mod Rheumatol; 2014 Mar; 24(2):316-20. PubMed ID: 24593207
[TBL] [Abstract][Full Text] [Related]
34. Detection of autoantibodies to killer immunoglobulin-like receptors using recombinant fusion proteins for two killer immunoglobulin-like receptors in patients with systemic autoimmune diseases.
Matsui T; Otsuka M; Maenaka K; Furukawa H; Yabe T; Yamamoto K; Nishioka K; Kato T
Arthritis Rheum; 2001 Feb; 44(2):384-8. PubMed ID: 11229470
[TBL] [Abstract][Full Text] [Related]
35. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
36. Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.
Lee HJ; Kim JH; Kim SW; Joo HA; Lee HW; Kim YS; Park SJ; Hong SP; Kim TI; Kim WH; Kim YH; Cheon JH
Dig Dis Sci; 2017 Aug; 62(8):1953-1962. PubMed ID: 28523576
[TBL] [Abstract][Full Text] [Related]
37. Anti-cardiolipin and anti-Neutrophil Cytoplasmic Antibodies in Iranian patients with Behcet's disease.
Ataollahi MR; Aflaki E; Nazarinia MA; Shenavandeh S; Habibagahi Z; Gharesi-Fard B; Kamali-Sarvestani E
Iran J Immunol; 2012 Dec; 9(4):241-7. PubMed ID: 23268290
[TBL] [Abstract][Full Text] [Related]
38. Prohibitin Is Involved in Patients with IgG4 Related Disease.
Du H; Shi L; Chen P; Yang W; Xun Y; Yang C; Zhao L; Zhou Y; Chen G
PLoS One; 2015; 10(5):e0125331. PubMed ID: 25932630
[TBL] [Abstract][Full Text] [Related]
39. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of antiepithelial cell antibody in systemic vasculitis and identification of the target antigen thereof].
Zheng WJ; Tang FL; Zhao Y; Chen H; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3272-6. PubMed ID: 16409818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
